REFERENCES
- Rotmensh S, Vishne TH, Celentano C, et at. Maternal infectious morbidity following multiple courses of betametha-sone. J Infect 1999;39:49–54
- Vermillion ST, Soper DE, Chasedunn-Roark J, et at. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1999;181:320–2
- Kadanali S, Ingec M, Kucukozkan T, et at. Changes in leukocyte, granulocyte and lymphocyte counts following antenatal betamethasone administration to pregnant women. Int J Gynaecol Obstet 1997;58:269–74
- Marconi AM, D'Amato B, Ronzoni S, et at. The effect of betamethasone on maternal amino acid concentrations in human pregnancy. J Soc Gynaecol Invest 2002;9:335 (abstr)
- Shelton SD, Boggess KA, Smith T, et at. Effect of betamethasone on maternal glucose. J Matern Fetal Neonat Med 2002;12:191–5
- Marinoni E, Korebrits C, Di Iorio R, et at. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998;178:770–8
- Derks JB, Mulder EJ, Visser OH. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995;102:40–6
- Cohlen BJ, Stigter RH, Derrks JB, et at. Absence of significant hemodynamic changes in the uterus following maternal betamethasone administration. Ultrasound Obstet Gynecol 1996;8:252–5
- Jobe AH, Wada N, Berry LM, et at. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998;178:880–5
- French N, Hagan R, Evans SF, et at. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114–21